Lumosa Therapeutics Co., Ltd
USPTO PatentsView assignee record - 6 granted patents across 1 technology areas, recorded in grant years 2019–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Lumosa ranks #41,513 of 49,997 tracked US assignees by granted-patent volume, with 6 patents across 1 technology areas.
- #41,513
- of 49,997 US assignees by volume
- Top 38%
- by Innovation Score (39.7/100)
- 15.7
- avg claims per patent
- +400%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R41513 · Foreign Corporation #41,513 · 6 grants
GRANTS-MICRO · LOWER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 6 grants
- LOWER-Q #41,513/49,997
- PHOTO-FINISH Lumicks CA Holding B V
- CPC-NARROW A61K · 1 areas
- INNOV-THIN 39.7/100
- CLAIMS-RICH 15.7 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +400% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Lumicks CA Holding B.V. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Lumosa’s 39.7 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Lumosa
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Hunter's Manufacturing · near
Hunter's Manufacturing · near
40 score
- Kantatsu · near
Kantatsu · near
40 score
- Lumosa Therapeutics · this assignee
Lumosa Therapeutics · this assignee
40 score
- Optis Cellular… · near
Optis Cellular… · near
40 score
- Smart Denture… · near
Smart Denture… · near
40 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Lumosa's Innovation Score is 39.7/100 (top 38% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Lumosa?
Each dot is one of Lumosa’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lumosa’s own 15.7 claims/patent is ABOVE the 14.0 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Lumosa's grants concentrate
Lumosa Therapeutics Co., Ltd is a focused PatentsView assignee: 1 CPC subclasses with 100% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (3 grants) versus a trough of 1 in 2019. By volume, Lumosa sits between Lumicks CA Holding B.V. and Lynceus SAS.
Lumosa's three-year grant acceleration
Lumosa Therapeutics Co., Ltd shows 5 grants in 2022–2024 against only 1 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Lumosa's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Lumicks CA Holdin…
Lumicks CA Holding B.V.
6 patents
- Lumileds Singapor…
Lumileds Singapore PTE. Ltd.
6 patents
- Luminous Cyber
Luminous Cyber Corporation
6 patents
- Lumos Labs
Lumos Labs, Inc.
6 patents
- Lure Enterprises…
Lure Enterprises Limited Liability Company
6 patents
- LUX BIO Group
LUX BIO Group Inc.
6 patents
- LWE
LWE, Inc.
6 patents
- Lynceus SAS
Lynceus SAS
6 patents
- Lumosa Therapeuti… ◀
Lumosa Therapeutics Co., Ltd
6 patents
What this shows Lumosa holds 6 patents at rank #41,391, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Lumosa
By rank, the assignees closest to #41,391 in granted patent volume.
- Lumicks CA Holding B.V. #41,387 · 6 patents
- Lumileds Singapore PTE. Ltd. #41,388 · 6 patents
- Luminous Cyber Corporation #41,389 · 6 patents
- Lumos Labs, Inc. #41,390 · 6 patents
- Lure Enterprises Limited Liability Company #41,392 · 6 patents
- LUX BIO Group Inc. #41,393 · 6 patents
- LWE, Inc. #41,394 · 6 patents
- Lynceus SAS #41,395 · 6 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Lumosa's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Lumosa, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Lumosa ranks #3,449 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (40 here).
Lumosa's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
40 Top 38% higher than 62% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 16.7% |
| 2022 | 3 | 50.0% |
| 2023 | 1 | 16.7% |
| 2024 | 1 | 16.7% |
Which technologies does Lumosa Therapeutics Co., Ltd patent most?
Top 1 of 1 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Lumosa Therapeutics Co., Ltd's patent record in context - here's where to go next.
- Lumosa Therapeutics Co., Ltd's lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 100% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #41,513 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Lumosa Therapeutics Co., Ltd against Lumicks CA Holding B.V., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 39.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.